- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05194657
Reading Performance in Patients With Acrysof IQ Vivity Versus Acrysof IQ
Assessment of Reading Performance in Patients With Acrysof IQ Vivity Toric or Non-toric vs Monofocal Acrysof IQ Toric or Non-toric IOL
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
With increasing demands of patients concerning their visual function after cataract surgery, a variety of advanced technology intraocular lenses (IOL) have become available in the last years. Various developments aim at a reduced spectacle independence for patients after cataract or refractive lens surgery.
Novel technology for providing an extended depth of focus (EDOF) has been developed to account for unmet needs of patients. A novel EDOF IOL, the Acrysof IQ Vivity, has two surface transition elements that work simultaneously by stretching and shifting the wavefront to create a continuous extended focal range instead of multiple focal points.
To assess the performance of such an IOL technology, most studies assess visual acuity at different distances from far, to intermediate up to near. Since most activites with digital devices implicate reading, it is not surprising that reading difficulty is the most common complaint among individuals experiencing visual disturbances with multifocal designs.
Reading ability is usually evaluated using various reading tests that assess reading speed and reading acuity defined as the print size that can stell be read with sufficient speed. However, one of the fundamental problems of these tests is that reading speed is also influenced by the average amount of time that a patient reads as well as the language of the text, whether it is the first or second language.
A novel method to analyse reading performance that appears to be more objective and less reliant on the cognitive abilities of the patient is the observation of the reading pattern using a high-speed eye-tracking system that analyses eye fixations during the reading test. In previous studies we have seen that several aspects of this reading patter, i.e. fixation duration and fixation frequency, appear to correlate with the reading performance overall and can be differentially used to discriminate between cognitive and visuo-motor processing.
Hence, the aim of this study is to assess the visual function and reading performance with an EDOF IOL (Acrysof IQ Vivity) compared to a standard monofocal IOL (Acrysof IQ).
136 eyes of 68 patients will be included into this study. According to the randomization, 34 patients will be implanted with the Acrysof IQ Vivity in both eyes and the other 34 patients will be implanted with the Acrysof IQ in both eyes. A follow-up examination will be performed at 3 months postoperative. During this visit a slitlamp examination, biometry and tomography of the eye, refraction and visual acuity assessment, an OCT examination, a retroillumination photogrypha, reading speed analysis and halometry will be performed.
Studietyp
Inskrivning (Förväntat)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Natascha Bayer, MSc
- Telefonnummer: 57564 01 91021
- E-post: office@viros.at
Studera Kontakt Backup
- Namn: Sahand Amir-Asgari, MD
- Telefonnummer: 57564 01 91021
- E-post: office@viros.at
Studieorter
-
-
-
Vienna, Österrike, 1140
- Rekrytering
- Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
-
Kontakt:
- Natascha Bayer, MSc
- Telefonnummer: 57564 01 91021
- E-post: office@viros.at
-
Kontakt:
- Sahand Amir-Asgari, MD
- Telefonnummer: 57564 01 91021
- E-post: office@viros.at
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Cataract
- Stereopsis
- age 21 and older
- regular corneal astigmatism of up to 3.0 D
- written informed consent prior to surgery
- normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
- availability, willingness and sufficient cognitive awareness to comply with examination procedures
- german as mother-tongue
- calculated IOL power needed is below 15.0 D or above 25.0 D (no high myopia or high hypermetropia will be recruited)
Exclusion Criteria:
- relevant other ophthalmic diseases such as: pseudoexfoliation, glaucoma, traumatic cataract, corneal scars, and other co-morbidity that could affect capsule bag stability (e.g. Marfan syndrome) or retinal diseases affecting visual acuity (AMD, Macular Pucker, post-operative macular edema...)
- amblyopia
- contact lenses
- irregular corneal astigmatism on corneal topography
- postoperative subjective refraction smaller/ higher than or 0.75 D
- pregnancy (pregnancy test will be taken preoperatively in women of reproductive age)
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Acrysof IQ Vivity
Patient will receive the enhanced depth of focus IOL during cataract surgery
|
Acrysof IQ Vivity, enhanced depth of focus IOL
|
Experimentell: Acrysof IQ
Patiet will receive the monofocal IOL during cataract surgery
|
Acrysof IQ, monofocal IOL
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Reading speed
Tidsram: 24 months
|
reading speed will be assessed with the Eyetracker device at 66 centimetres and will be compared between the EDOF IOL and the monofocal IOL
|
24 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Visual acuity
Tidsram: 24 months
|
Visual acuity will be assessed using the ETDRS charts and will be compared between the EDOF IOLs and the monofocal IOLs
|
24 months
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- Vivity
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på enhanced depth of focus IOL
-
Newsom Eye & Laser CenterAvslutadGrå starrFörenta staterna
-
Alcon ResearchAvslutadGrå starrAustralien, Spanien, Kanada, Storbritannien
-
Alcon ResearchAvslutadGrå starrFörenta staterna
-
Cambridge Health AllianceAvslutadPediatrisk mentalvårdFörenta staterna
-
University of North Carolina, Chapel HillCenters for Disease Control and Prevention; Centre for Infectious Disease...Avslutad
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Har inte rekryterat ännuTyp 1-diabetesFörenta staterna
-
Brown UniversityNational Institute of Mental Health (NIMH); University of Cape TownAvslutadHIV | GraviditetsrelateradSydafrika
-
Duke UniversityNational Institute of Mental Health (NIMH); Kilimanjaro Christian Medical...Aktiv, inte rekryterandeHIV-infektioner | Livskvalité | Självmordstankar | Självmord | Följsamhet, medicinering | Behandlingsefterlevnad och efterlevnad | Stigma, social | AvslöjandeTanzania
-
Abbott Medical OpticsAvslutad